| An analysis of survival in patients with castrate-resistant prostate cancer receiving enzalutamide with treatment breaks MP Rowe, S Walter, A Hidayat, A Pollard, T Norris, D Victor, J McGrane, ... Journal of Clinical Urology 15 (3), 257-263, 2022 | 1 | 2022 |
| The Impact of Treatment Crossover and Prostate-specific Antigen Flare with Enzalutamide and Abiraterone in Metastatic Castrate Resistant Prostate Cancer J McGrane, M Rowe, A Hidayat, S Walter, D Victor, T Norris, A Pollard Clinical Oncology 33 (1), e92, 2021 | 1 | 2021 |
| The use of intermittent enzalutamide dosing in the treatment of metastatic castrate-resistant prostate cancer. M Rowe, A Hidayat, S Walter, A Pollard, T Norris, D Victor, J McGrane, ... Journal of Clinical Oncology 38 (6_suppl), 81-81, 2020 | 1 | 2020 |
| Science Repository M Rowe, S Walter, A Hidayat, H Donkers, A Browne, T Norris, A Pollard, ... | | 2020 |
